Clearlake explores Symplr stake sale, seeking $2bn valuation

The Santa Monica buyout firm bought Symplr in 2018 in a transaction valuing the healthcare software company at about $550 million.

Clearlake Capital Group is evaluating strategic options for Symplr, a provider of healthcare governance, risk and compliance software, according to five sources familiar with the matter. 

Less than two years into its investment, the Santa Monica, California, firm is exploring a minority stake sale or 50-50 joint ownership transaction that brings in another private equity group, sources said. 

William Blair and Goldman Sachs are providing financial advice on the process, the sources said. 

The sellers are expecting a potential transaction to value the Houston company around $2 billion, some of the people said. Based upon Symplr’s approximately $80 million in EBITDA, that would imply a multiple of about 25x. 

Clearlake in October 2018 agreed to buy Symplr in a transaction valuing the provider of healthcare-credentialing software at about $550 million, PE Hub wrote. SkyKnight Capital co-invested in the deal. 

The company was previously backed by Pamlico Capital and CapStreet Group.

Symplr under Clearlake has continued to expand beyond software that helps healthcare providers track and manage the credentials of physicians, visitors, staff and contractors. Today its Software-as-a-Service platform spans credentialing, data management, payer enrollment services, patient safety, workforce management and vendor management. 

Its growth has been driven in part through M&A.

Notably, Symplr in early 2019 clinched a close to $300 million deal for API Healthcare, acquiring the workforce management software company from Veritas Capital. The company later in the year bought IntelliSoft Group, another credentialing software provider. 

More recently, Symplr in February bought The Patient Safety Company from Main Capital Partners, expanding into patient safety and incident tracking and reporting.

The process for Symplr follows more than one high-profile deal in healthcare technology, with assets showing resilience through the downturn continuing to command premium valuations.

In one of the sector’s largest deals of the year, Leonard Green & Partners bought a 50 percent stake in WellSky from TPG. The deal valued the healthcare software company north of $3 billion, surpassing a 20x EBITDA multiple. 

In June, ICONIQ Capital, known for its ties to tech billionaires such as Facebook CEO Mark Zuckerburg, joined Francisco Partners as an investor in QGenda. At a $1.05 billion valuation, the deal commanded more than 26x the workforce management company’s approximately $40 million in EBITDA. 

Clearlake and Goldman Sachs declined to comment. Skyknight, Symplr and WellSky did not return requests for comment. 

Action Item: Check out Clearlake’s latest Form ADV